Episode Details

Australia braces for national puberty blocker guidelines as states like Queensland and the Northern Territory impose restrictions, sparking global debate over safety, consent, and long-term effects. While teens like 16-year-old Kassie credit blockers with easing gender dysphoria, critics call them experimental and question children’s capacity to consent. Amid a lack of large-scale trials and diverging international policies—from the UK’s bone health concerns to Trump’s U.S. funding cuts—experts clash over evidence standards. As Australia moves toward 2028 final guidelines, the federal government seeks unity, but state-level decisions may still create a patchwork of care.

Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/e77198373a335644